First-in-class oral drug improves embryo implantation and pregnancy outcomes in IVF

FHS
July 8, 2024
2:22 pm

New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Flush with cash, Novo Nordisk Foundation now plans to reinvest some GLP-1 profits into regenerative medicines

The Novo Nordisk Foundation, the majority owner of Novo Nordisk, plans to put more money into regenerative medicines, including stem cells and cell therapies for

May 31, 2024

Acetaminophen use in pregnancy linked to children’s language delays

Increased use of acetaminophen during pregnancy is associated with potential language development issues in children, emphasizing the need for caution and further research into its

March 13, 2024

Children may have experienced “excess” doubling up during COVID-19 pandemic

Grandparents appeared to serve as an important private safety net when COVID-19 first hit the U.S., according to a study led by a Washington State

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.